Intravitreal aflibercept for neovascular AMD in the very elderly neovascular AMD patients: UK Multi-centre Real World Outcome

被引：0
|
作者：
Talks, James [1 ]
Sivaprasad, Sobha [2 ]
机构：
[1] Newcastle Upon Tyne Hosp NHS Fdn Trust, Ctr Eye, Newcastle Upon Tyne, Tyne & Wear, England
[2] Moorfields Eye Hosp, London, England
来源：
INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE | 2017年 / 58卷 / 08期
关键词：
D O I：
暂无
中图分类号：
R77 [眼科学];
学科分类号：
100212 ;
摘要：
911
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Real-world visual acuity outcomes between ranibizumab and aflibercept in treatment of neovascular AMD in a large US data set
    Lotery, A.
    Griner, R.
    Ferreira, A.
    Milnes, F.
    Dugel, P.
    EYE, 2017, 31 (12) : 1697 - 1706
  • [22] Short-Term Comparison of Switching to Brolucizumab or Faricimab from Aflibercept in Neovascular AMD Patients
    Kin, Akiko
    Mizukami, Takahiro
    Ueno, Satoru
    Mishima, Soichiro
    Shimomura, Yoshikazu
    MEDICINA-LITHUANIA, 2024, 60 (07):
  • [23] Vision improvement maintained at year 2 in patients with persistent neovascular AMD requiring intensive intravitreal aflibercept monotherapy through week 56
    Patel, Nishal
    Sivaprasad, Sobha
    Talks, James
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [24] Intravitreal Nesvacumab (Anti-Angiopoietin-2) Plus Aflibercept in Neovascular AMD: Phase 2 ONYX Randomized Trial
    Heier, Jeffrey S.
    Ho, Allen C.
    Boyer, David S.
    Csaky, Karl
    Vitti, Robert
    Perlee, Lorah
    Chu, Karen W.
    Asmus, Friedrich
    Leal, Sergio
    Zeitz, Oliver
    Cheng, Yenchieh
    Schmelter, Thomas
    Brown, David M.
    JOURNAL OF VITREORETINAL DISEASES, 2023, 7 (01) : 8 - 15
  • [25] Real-World Use of Off-Label MVASI in the Treatment of Patients With Neovascular AMD and DME
    Lombardo, Marco
    Missiroli, Filippo
    Cerri, Luca
    Sorge, Roberto P.
    Cesareo, Massimo
    Ricci, Federico
    TRANSLATIONAL VISION SCIENCE & TECHNOLOGY, 2024, 13 (07):
  • [26] Retinal Venular Caliber Predicts Visual Outcome after Intravitreal Ranibizumab Injection Treatments for Neovascular AMD
    Wickremasinghe, Sanjeewa S.
    Busija, Lucy
    Guymer, Robyn H.
    Wong, Tien Y.
    Qureshi, Salmaan
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2012, 53 (01) : 37 - 41
  • [27] The UK Neovascular AMD Database Report 3: inter-centre variation in visual acuity outcomes and establishing real-world measures of care
    Liew, G.
    Lee, A. Y.
    Zarranz-Ventura, J.
    Stratton, I.
    Bunce, C.
    Chakravarthy, U.
    Lee, C. S.
    Keane, P. A.
    Sim, D. A.
    Akerele, T.
    McKibbin, M.
    Downey, L.
    Natha, S.
    Bailey, C.
    Khan, R.
    Antcliff, R.
    Armstrong, S.
    Varma, A.
    Kumar, V.
    Tsaloumas, M.
    Mandal, K.
    Egan, C.
    Johnston, R. L.
    Tufail, A.
    EYE, 2016, 30 (11) : 1462 - 1468
  • [28] The UK Neovascular AMD Database Report 3: inter-centre variation in visual acuity outcomes and establishing real-world measures of care
    G Liew
    A Y Lee
    J Zarranz-Ventura
    I Stratton
    C Bunce
    U Chakravarthy
    C S Lee
    P A Keane
    D A Sim
    T Akerele
    M McKibbin
    L Downey
    S Natha
    C Bailey
    R Khan
    R Antcliff
    S Armstrong
    A Varma
    V Kumar
    M Tsaloumas
    K Mandal
    C Egan
    R L Johnston
    A Tufail
    Eye, 2016, 30 : 1462 - 1468
  • [29] VEGF dosage curve in the aqueous humor after bevacizumab intravitreal injection in patients with neovascular AMD
    Cabral, Thiago
    Polido, Julia
    Okuda, Erika Araki
    Oshima, Akiyoshi
    Serracarbassa, Pedro
    Belfort, Rubens, Jr.
    Regatieri, Caio
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2015, 56 (07)
  • [30] Characterization of Patients With Neovascular AMD That Had Opposing Responses to Intravitreal Anti-VEGF Therapy
    Mendonca, L. F.
    Falcao, M.
    Fonseca, S.
    Brandao, E.
    Falcao-Reis, F.
    Carneiro, A.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2010, 51 (13)
12345